XOMAP FY 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+246.7% YoY

Gross Profit

$17M93.2% margin

Operating Income

-$4M-21.1% margin

Net Income

-$2M-10.8% margin

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$285,000

Free Cash Flow

-$20M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$96M

Total Liabilities

$52M

Stockholders' Equity

$44M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$5M	+246.7%
Gross Profit	$17M	$4M	+373.2%
Operating Income	-$4M	-$17M	+77.0%
Net Income	-$2M	-$13M	+85.1%